Risk factors for respiratory failure in pneumococcal pneumonia: The importance of pneumococcal serotypes

European Respiratory Journal

Volumn 43, Issue 2, 2014, Pages 545-553

  Burgos, Joaquín ^a   Luján, Manel ^b,c   Larrosa, Maria Nieves ^a   Fontanals, Dionísia ^b   Bermudo, Guadalupe ^b   Planes, Ana Maria ^c   Puig, Mireia ^a,d   Rello, Jordi ^a,c   Falco, Vicenc ^a   Pahissa, Albert ^a,d  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTI-BACTERIAL AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SEROTYPING; SHOCK, SEPTIC; SPAIN; STREPTOCOCCUS PNEUMONIAE; TREATMENT OUTCOME;

EID: 84893506755     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00050413     Document Type: Article

References (30)

1. Varon E, Mainardi JL, Gutmann L. Streptococcus pneumoniae: still a major pathogen. Clin Microbiol Infect 2010; 16: 401.
2. Lipsky BA, Boyko EJ, Inui TS, et al. Risk factors for acquiring pneumococcal infections. Arch Intern Med 1986; 146: 2179-2185.
3. Musher DM. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 1992; 14: 801-809.
4. Alanee SR, McGee L, Jackson D, et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45: 46-51.
5. Guckian JC, Christensen GD, Fine DP. The role of opsonins in recovery from experimental pneumococcal pneumonia. J Infect Dis 1980; 142: 175-190.
6. Engerlhad D, Pomeranz S, Gallily R, et al. Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis. J Infect Dis 1997; 175: 979-982.
7. Brueggemann AB, Peto TE, Crook DW, et al. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190: 1203-1211.
8. Sjöström K, Spindler C, Ortqvist A, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006; 42: 451-459.
9. Jansen AG, Rodenburg GD, van der Ende A, et al. Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis 2009; 49: e23-e29.
10. Burgos J, Falcó V, Borrego A, et al. Impact of the emergence of non-vaccine pneumococcal serotypes on the clinical presentation and outcome of adults with invasive pneumococcal pneumonia. Clin Microbiol Infect 2013; 19: 385-391.
11. Garcia-Vidal C, Ardanuy C, Tubau F, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010; 65: 77-81.
12. Azoulay E, Mokart D, Lambert J, et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 1038-1046.
13. PIDIRAC. Canal Salut. www20.gencat.cat/portal/site/canalsalut/menuitem. 41e04b39494f1be3ba963bb4b0c0e1a0/ ? vgnextoid5db0d438bd384c310VgnVCM2000009b0c1e0aRCRD& vgnextchannel5db0d438bd384c310VgnVCM 2000009b0c1e0aRCRD&vgnextfmt5default Date last updated: June 25, 2013. Date last accessed: February 28, 2013.
14. Clinical and Laboratory Standard Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement. CLSI document M100-S22. Wayne, Clinical and Laboratory Standards Institute, 2012.
15. Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006; 25: 250-254.
16. Burgos J, Lujan M, Falcó V, et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 2011; 53: 254-261.
17. Weinberger DM, Harboe ZB, Sanders EA, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51: 692-699.
18. Harboe ZB, Thomsen RW, Riis A, et al. Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study. PLoS Med 2009; 6: e1000081.
19. Weinberger DM, Trzciński K, Lu YJ, et al. Pneumococcal capsular polysaccharide structure predicts serotype prevalence. PLoS Pathog 2009; 5: e1000476.
20. Sanchez CJ, Hinojosa CA, Shivshankar P, et al. Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence. PLoS One 2011; 6: e26587.
21. Rello J, Lisboa T, Lujan M, et al. Severity of pneumococcal pneumonia associated with genomic bacterial load. Chest 2009; 136: 832-840.
22. Werno AM, Anderson TP, Murdoch DR. Association between pneumococcal load and disease severity in adults with pneumonia. J Med Microbiol 2012; 61: 1129-1135.
23. Waterer GW, Quasney MW, Cantor RM, et al. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001; 163: 1599-1604.
24. Marfin A, Sporrer J, Moore P, et al. Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest 1995; 107: 457-462.
25. Quasney MW, Waterer GW, Dahmer MK, et al. Association between surfactant protein B + 1580 polymorphism and the risk of respiratory failure in adults with community-acquired pneumonia. Crit Care Med 2004; 32: 1115-1119.
26. Johnstone J, Marrie TJ, Eurich DT, et al. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 2007; 167: 1938-1943.
27. Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 2006; 42: 1093-1101.
28. Imaz A, Falcó V, Peñaranda M, et al. Impact of prior pneumococcal vaccination on clinical outcomes in HIVinfected adult patients hospitalized with invasive pneumococcal disease. HIV Med 2009; 10: 356-363.
29. Grijalva G, Griffin M. Unveiling the burden of influenza-associated pneumococcal pneumonia. J Infect Dis 2012; 205: 355-357.
30. McCullers JA. Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev 2006; 19: 571-582.